Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas

H-J Kwak1, Y-J Kim, K-R Chun

  • 1Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

Oncogene
|February 1, 2011
PubMed

Insights

MicroRNAs like miR-21 drive glioma invasion by disrupting Spry2 regulation in PTEN-deficient tumors. Decreased Spry2 protein in gliomas suggests miR-21 as a therapeutic target for improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gliomas are highly invasive brain tumors with poor prognosis.
  • Understanding the molecular basis of glioma invasion is crucial for developing effective treatments.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in cancer progression and metastasis.

Purpose of the Study:

  • To investigate the role of microRNA deregulation in glioma invasion.
  • To elucidate the molecular mechanisms underlying the onset of glioma invasiveness.
  • To identify potential therapeutic targets for combating glioma malignancy.

Main Methods:

  • Analysis of miR-21 expression and its impact on the Ras/MAPK signaling pathway.
  • Investigation of Spry2 as a target of miR-21.
  • Correlation of Spry2 protein levels with miR-21 levels in human glioma tissues.
  • Assessment of the influence of tumor microenvironmental factors (hyaluronan, growth factors) on miR-21 upregulation in PTEN-deficient cells.

Main Results:

  • Aberrant miR-21 expression disrupts the Ras/MAPK signaling pathway via Spry2, promoting glioma invasion.
  • miR-21 upregulation is associated with PTEN deficiency and triggered by microenvironmental factors.
  • Significantly decreased Spry2 protein levels were observed in invasive WHO grade II-IV gliomas but not in normal or non-invasive grade I tissues.
  • Spry2 protein levels showed an inverse correlation with miR-21 levels, independent of mRNA levels, indicating post-transcriptional regulation.

Conclusions:

  • Post-transcriptional regulation of Spry2 by miR-21 plays a critical role in the malignant progression of human gliomas.
  • Spry2 represents a potential novel therapeutic target for glioma treatment.
  • Targeting miR-21 or restoring Spry2 function could offer new avenues for glioma therapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...